Search

Your search keyword '"Leoni, Pietro"' showing total 729 results

Search Constraints

Start Over You searched for: Author "Leoni, Pietro" Remove constraint Author: "Leoni, Pietro"
729 results on '"Leoni, Pietro"'

Search Results

1. Roboat II: A Novel Autonomous Surface Vessel for Urban Environments

2. Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

5. Roboat III: An autonomous surface vessel for urban transportation

7. Smart curbs: Measuring street activities in real-time using computer vision

8. Tracking stolen bikes in Amsterdam

9. Tracking stolen bikes in Amsterdam

10. Tracking stolen bikes in Amsterdam

13. Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin

15. Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD

16. Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides

18. Roboat II: A Novel Autonomous Surface Vessel for Urban Environments

20. Assessment of Vulnerability Measures and Their Effect on Survival in a Real-Life Population of Multiple Myeloma Patients Registered at Marche Region Multiple Myeloma Registry

22. Design of an Autonomous Latching System for Surface Vessels

25. Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

27. Trajectory Planning for the Shapeshifting of Autonomous Surface Vessels

28. Design, Modeling, and Nonlinear Model Predictive Tracking Control of a Novel Autonomous Surface Vehicle

29. Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto (GIMEMA) Leukemia Cooperative Groups

35. Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

37. Risk of Non-Hodgkin Lymphoma in Celiac Disease. (Original Contribution)

41. ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma

43. Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study

44. A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol

46. Thalidomide-dexamethasone versus Interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study

48. Serum C-Reactive Protein at Diagnosis and Response to Therapy Is the Most Powerful Factor Predicting Outcome of Multiple Myeloma Treated with Thalidomide/Anthracycline-Based Therapy

Catalog

Books, media, physical & digital resources